Lobbying ramps up around new health agency headquarters - Roll Call At least 10 states have expressed interest in hosting the new agency, tasked with speeding to market innovative health technologies. Roll Call · Jul 28, 2022
Psychedelics And The National Institutes Of Health—How Do They Relate? As David Hodes first noted in The Green Market Report, the U.S. National Institutes of Health (NIH)’s growing interest in psychedel Benzinga · Jul 26, 2022
Johns Hopkins University can continue barn owl testing after permit battle with PETA BALTIMORE — A Johns Hopkins University researcher can continue medical experiments on barn owls after a lengthy battle with the People for the Ethical Treatment of Animals over animal cruelty and permit complaints. Tribune News Service · Jul 12, 2022
Long Covid: what we know about it and how best to treat it Symptoms can persist for weeks but work on causes and treatments is still developing. Here’s what we know so far The Guardian - AU · Jul 9, 2022
Biomedical grantmakers' diversity push gains new momentum The Howard Hughes Medical Institute, one of the nation’s wealthiest philanthropies, announced a $1.5 billion effort designed to help scientists of color advance in their careers The Independent UK · Jul 6, 2022
Indiana University Neuroscientists Receive $2M To Conduct Study On Impact Of Cannabis Use During Adolescence Recently, Neuroscientists from the Indiana University (IU) Gill Center for Biomolecular Science received more than $2 million from the NIH's National Institute on Drug Abuse&nbs Benzinga · Jul 5, 2022
Federal Health Officials' Letter To Senators: Psychedelics Illegal Status Limits Research As reported by Marijuana Moment, officials of the U.S. National Institutes of Health (NIH) replied to two senators’ request for a psychedelics research update with a letter stating that federal prohibit Benzinga · Jul 1, 2022
Male birth control is at our fingertips. Will we ever grasp it? The research behind hormonal male birth control is about as old as the pill. But a safe and effective candidate is tantalizingly close to market. Inverse · Jun 30, 2022
Efficacy Of Pfizer's Paxlovid COVID Drug Crashes, According To New NIH-Funded Study A new National Institutes of Health (NIH) funded study sheds new light on the waning effectiveness of Pfizer’s (NYSE: PFE) Paxlovid to prevent patient hospitalizations due to COVID. Benzinga · Jun 29, 2022
Pakistan orders masks on domestic flights as COVID numbers rise Pakistan’s aviation regulator has made masks mandatory on domestic flights given a gradual rise in the number of COVID-19 cases across the country, it said a statement. Reuters · Jun 27, 2022
MNOV: Positive Results for MN-166 (Ibudilast) in Patients at Risk of Acute Respiratory Distress Syndrome… By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Benzinga · Jun 18, 2022
Dr Fauci, renowned pandemic adviser, tests positive for COVID Dr Fauci became a household name for his reassuring and professional presence early in the pandemic. Al Jazeera · Jun 15, 2022
Anthony Fauci on the Aids crisis, monkeypox, trans rights and his retirement In an exclusive interview with Io Dodds, Dr Anthony Fauci looks back on his decades-long career in public health The Independent UK · Jun 15, 2022
Tribune News Service · Jun 15, 2022 Dr. Fauci tests positive for COVID Dr. Anthony Fauci tested positive for COVID on Wednesday morning.
The Guardian - US · Jun 15, 2022 Anthony Fauci tests positive for Covid with mild symptoms Biden’s chief medical adviser received two booster shots and is working from home, says National Institutes of Health
Benzinga · Jun 15, 2022 Pfizer Halts Enrollment In Paxlovid COVID-19 Trial In Standard-Risk Population Pfizer Inc (NYSE:PFE) shared additional data from the Phase 2/3 EPIC-SR study of Paxlovid (nirmatrelvir and ritonavir tablets) in patients at standard risk for developing severe COVID-19. In previously reported interim analyses, the novel primary endpoint of self-reported, sustained alleviation of all symptoms for four consecutive days was not met. Non-significant 70% relative…
The Independent UK · Jun 8, 2022 Exclusive: Anthony Fauci on the Aids crisis, monkeypox, trans rights and his retirement (OLD) In an exclusive interview with Io Dodds, Dr Anthony Fauci looks back on his decades-long career in public health
Roll Call · Jun 7, 2022 Congress remembers John E. Porter, appropriator and advocate for NIH - Roll Call Lawmakers are paying tribute to former Rep. John E. Porter, an Illinois Republican and Appropriations “cardinal” who died Friday at age 87.
Salon · May 29, 2022 Adam ruins government & criticizes Obama Netflix's "The G Word" host tells Salon government is "astonishing" when it works and how to stop doomscrolling
Tribune News Service · May 17, 2022 Commentary: One monkey’s story I want to tell you a story. It’s about a prisoner—a prisoner who has endured horrors the likes of which we can scarcely imagine.
Benzinga · May 13, 2022 Biden Says US Ready To Share COVID-19 Vaccine Related Technology President Joe Biden said that the U.S. will share technologies used to make COVID-19 vaccines through the World Health Organization and is working on expanding rapid testing and antiviral treatments for hard-to-reach populations. "We are making available health technologies that are owned by the United States government, including stabilized spike protein that…
The Conversation · May 13, 2022 Why a US task force is recommending anxiety screening in kids 8 and older The U.S. Preventive Services Task Force issued a draft statement in April 2022 recommending screening for anxiety in children and adolescents between the ages of 8 and 18. This recommendation – which is still open for public comment – is timely, given the impact of the COVID-19 pandemic on children’s…
Benzinga · May 12, 2022 Senators Cory Booker And Brian Schatz Call On Federal Agencies To Research Psychedelics Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the FDA whom they called on to study the therapeutic potent
The Philadelphia Inquirer · May 3, 2022 How one professor's work to save teachers' voices is part of new research focus PHILADELPHIA — Managing a classroom takes a lot, including a strong voice that can lift over the chatter of 30-some students.